Jobs für executive school bei Basel
8 executive school Stellenangebote in Schweiz. Täglich aktualisierte Angebote.
-
Corporate Counsel(Manager/Sr. Manager)
Vor 4 Stunden
Basel, Basel-Stadt, Schweiz Mirum Pharmaceuticals, Inc. Vollzeitph3MISSION /h3 pMirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. We are passionate about advancing scientific discoveries to become important medicines for rare disease patients. We are collaborative, creative, and experienced professionals and we’re looking to augment our team with other...
-
Basel, Basel-City, Schweiz Revolution Medicines VollzeitRevolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target...
-
Corporate Counsel(Manager/Sr. Manager) Premium
Vor 6 Tagen
Basel, Schweiz Mirum Pharmaceuticals VollzeitMISSION Mirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. We are passionate about advancing scientific discoveries to become important medicines for rare disease patients. We are collaborative, creative, and experienced professionals and we’re looking to augment our team with other individuals...
-
Corporate Counsel(Manager/Sr. Manager)
Vor 3 Wochen
Basel, Basel, BS, Schweiz Mirum Pharmaceuticals, Inc. Vollzeit**MISSION** Mirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. We are passionate about advancing scientific discoveries to become important medicines for rare disease patients. We are collaborative, creative, and experienced professionals and we’re looking to augment our team with other...
-
Basel, Basel, BS, Schweiz Revolution Medicines VollzeitRevolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor;...
